| (CNY) | Mar 2015 | Y/Y change |
|---|---|---|
| Revenue | 1.62B | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 600329.SS returned -12.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -12.3% |
| 1 year | -12.6% |
| 5 years | +38.9% |
| 10 years | +175.2% |
| All-time high | ¥54.69 (May 2023) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 600329.SS would be worth today ›Yes. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited paid 2 dividends over the past 12 months. The most recent was ¥2.34 per share on Jul 10, 2026. The dividend yield is 13.41%.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is part of the Healthcare sector.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has a market cap of 27.51B CNY, based on the latest quote.
